VRNA
Price:
$106.91
Market Cap:
$72.68B
Verona Pharma plc is a biopharmaceutical company currently in its clinical development phase, focusing on the research, development, and eventual market launch of new therapies for respiratory illnesses where current treatments are inadequate. Its primary experimental medication is ensifentrine, an inhaled compound designed to simultaneously block both phosphodiesterase (PDE) 3 and PDE4 enzymes. This unique mechanism allows it to function both as a bronchodilator, helping to open the airways, and as an anti-inflammatory agent within a single drug. Ensifentrine is presently undergoing advanced (Phase 3) clinical trials to evaluate its effectiveness in treating chronic obstructive pulmonary di...[Read more]
Industry
Biotechnology
IPO Date
2017-04-28
Stock Exchange
NASDAQ
Ticker
VRNA
According to Verona Pharma plc’s latest financial reports and current stock price. The company's current Current Ratio is 10.71. This represents a change of -0.89% compared to the average of 10.81 of the last 4 quarters.
The mean historical Current Ratio of Verona Pharma plc over the last ten years is 10.44. The current 10.71 Current Ratio has changed 10.16% with respect to the historical average. Over the past ten years (40 quarters), VRNA's Current Ratio was at its highest in in the December 2023 quarter at 33.33. The Current Ratio was at its lowest in in the March 2016 quarter at 0.
Average
10.44
Median
7.83
Minimum
3.07
Maximum
33.33
Discovering the peaks and valleys of Verona Pharma plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 161.01%
Maximum Annual Current Ratio = 33.33
Minimum Annual Increase = -85.68%
Minimum Annual Current Ratio = 3.07
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 10.63 | -68.12% |
| 2023 | 33.33 | 161.01% |
| 2022 | 12.77 | 150.96% |
| 2021 | 5.09 | -64.31% |
| 2020 | 14.26 | 157.58% |
| 2019 | 5.54 | 0.21% |
| 2018 | 5.52 | -45.47% |
| 2017 | 10.13 | 151.39% |
| 2016 | 4.03 | 31.09% |
| 2015 | 3.07 | -85.68% |
The current Current Ratio of Verona Pharma plc (VRNA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
18.91
5-year avg
15.21
10-year avg
10.44
Verona Pharma plc’s Current Ratio is greater than Seagen Inc. (2.12), greater than Becton, Dickinson and Company (0.87), greater than Alpine Immune Sciences, Inc. (7.86), greater than ImmunoGen, Inc. (2.26), greater than BeOne Medicines AG (3.40), less than Prometheus Biosciences, Inc. (31.04), greater than Reata Pharmaceuticals, Inc. (6.75), greater than ERYTECH Pharma S.A. (1.06), less than Karuna Therapeutics, Inc. (19.31), greater than Blueprint Medicines Corporation (2.85),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.12 | $43.15B | |
| 0.87 | $50.53B | |
| 7.86 | $4.46B | |
| 2.26 | $8.73B | |
| 3.40 | $37.13B | |
| 31.04 | $9.56B | |
| 6.75 | $6.57B | |
| 1.06 | $47.38M | |
| 19.31 | $12.60B | |
| 2.85 | $8.36B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Verona Pharma plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Verona Pharma plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Verona Pharma plc's Current Ratio?
How is the Current Ratio calculated for Verona Pharma plc (VRNA)?
What is the highest Current Ratio for Verona Pharma plc (VRNA)?
What is the 3-year average Current Ratio for Verona Pharma plc (VRNA)?
What is the 5-year average Current Ratio for Verona Pharma plc (VRNA)?
How does the current Current Ratio for Verona Pharma plc (VRNA) compare to its historical average?